|
Recent Developments |
|
09-SEP-15
Bal Pharma, an Indian pharmaceutical company, announced the launch of its maiden OTC (over the counter) product 'Eye Spa', in Bangalore market. This is first among the series of OTC products that the company has lined up for launching in the market through its subsidiary i.e Lifezen Healthcare.
19-MAR-15
Bal Pharma announced that the company, in the capacity of promoter of Lifezen Healthcare which is incorporated with proposed object... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 31-Mar-2016(12) | 31-Mar-2015 (12) | 31-Mar-2014 (12) | | Net sales | 1941.63 | 1824.57 | 1734.14 | | Other Income | 14.96 | 11.95 | 6.46 | | Total Income | 1956.59 | 1836.52 | 1740.60 | | Cost of goods sold | 1805.16 | 1696.04 | 1609.95 | | OPBDIT | 151.43 | 140.48 | 130.65 | | PAT | 28.07 | 40.23 | 50.72 | | Gross Block | - | - | - | | Equity capital | 128.72 | 128.72 | 111.11 | | EPS (Rs.) | - | 3.14 | 4.77 | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | 9.25 - 33.06 | 2.84 - 8.72 | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 7.7 | 7.6 | 7.5 | | Net margin (% of OI) | 1.4 | 2.2 | 2.9 |
|
|
Detailed Financials
|
|
|
|
|
